Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02096198 · ClinicalTrials.gov registry record
Ceramic On Ceramic (COC) 36mm PAS IDE Rollover Subjects; Ceramic Acetabular Bearing With Ceramic Femoral Head in Total Hip Replacement
A clinical trial of Osteoarthritis and Avascular Necrosis, sponsored by DePuy Orthopaedics.
- Completed
- Registry status
- 81
- Enrollment target
- 5
- Study locations
NCT02096198 is a study of Osteoarthritis and Avascular Necrosis that has completed, run by DePuy Orthopaedics. The registered enrollment target is 81 participants, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (90% lower). The trial reports 5 study locations across 5 states.
The verdict
NCT02096198, a study of Osteoarthritis and Avascular Necrosis, has completed, sponsored by DePuy Orthopaedics.
- COMPLETED
- Registry status
- 81 participants
- Enrollment target
- 5
- Study locations
Study Summary
This study is intended to gather medium (5- to 7-years) and long-term (minimum 8- to 10-years) information regarding the performance and safety of the commercially available 36mm CERAMAX® Ceramic on Ceramic (COC) Total Hip System from a cohort of study subjects that were previously enrolled in the IDE study. (COC = 36mm ceramic acetabular bearing insert component that articulates with a ceramic femoral head in the COC total hip replacement system)
Conditions Studied
Study Locations (5)
California
- - Sacramento
Colorado
- - Denver
North Carolina
- - Winston-Salem
Ohio
- Orthopedic One - Columbus
Virginia
- - Alexandria
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2014-01-01 |
| Est. Completion | 2018-08-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02096198
The ClinicalTrials.gov registry entry for NCT02096198 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (90% lower). The listed sponsor is DePuy Orthopaedics, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Osteoarthritis appearing as the primary indexed condition, and to 0 interventions.
NCT02096198 reports 5 study locations spanning 5 distinct geographic areas - top geographies include California, Colorado, North Carolina.
Frequently Asked Questions
What is clinical trial NCT02096198 about?
NCT02096198 is a clinical study titled "Ceramic On Ceramic (COC) 36mm PAS IDE Rollover Subjects; Ceramic Acetabular Bearing With Ceramic Femoral Head in Total Hip Replacement". This study is intended to gather medium (5- to 7-years) and long-term (minimum 8- to 10-years) information regarding the performance and safety of the commercially available 36mm CERAMAX® Ceramic on Ceramic (COC) Total Hip System from a cohort of study subjects that were previously enrolled in the I...
What is the current status of trial NCT02096198?
This trial is currently completed. The enrollment target is 81 participants. The study started on 2014-01-01. Estimated completion is 2018-08-20.
What conditions does trial NCT02096198 study?
This clinical trial studies the following conditions: Osteoarthritis, Avascular Necrosis, Non-inflammatory Degenerative Joint Disease, Post-Traumatic Osteoarthritis of Hip.
Who is sponsoring clinical trial NCT02096198?
This trial is sponsored by DePuy Orthopaedics, which has 38 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02096198 being conducted?
This trial has 5 study locations across California, Colorado, North Carolina, Ohio, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Knee
RECRUITING · Phase 2
-
A Prospective, Post-Market, Clinical Follow-up Study of the Incompass™ Total Ankle System
RECRUITING
-
Reliability of Pupil Response to Acute Pain
RECRUITING
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Ketorolac in Upper Extremity Tendinopathy and Arthropathy
RECRUITING · Phase 4
-
The PROACTIVE Study for Black Elders
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.